Wolverine Asset Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | -$171 | – | 1626 |
|
|
2024
Q3 | $171 | Hold |
100
| – | – | ﹤0.01% | 1606 |
|
|
2024
Q2 | $117 | Hold |
100
| – | – | ﹤0.01% | 1634 |
|
|
2024
Q1 | $99 | Hold |
100
| – | – | ﹤0.01% | 1628 |
|
|
2023
Q4 | $392 | Buy |
+100
| New | +$529 | ﹤0.01% | 1671 |
|
|
2022
Q3 | – | Sell |
-1,120
| Closed | -$11K | – | 2389 |
|
|
2022
Q2 | $11K | Buy |
1,120
+400
| +56% | +$3.53K | ﹤0.01% | 1956 |
|
|
2022
Q1 | $10K | Buy |
720
+340
| +89% | +$9.68K | ﹤0.01% | 1890 |
|
|
2021
Q4 | $19K | Buy |
+380
| New | +$21.2K | ﹤0.01% | 1724 |
|
|
2021
Q2 | – | Sell |
-5,940
| Closed | -$494K | – | 2162 |
|
|
2021
Q1 | $494K | Sell |
5,940
-1,390
| -19% | -$141K | ﹤0.01% | 914 |
|
|
2020
Q4 | $555K | Buy |
7,330
+4,940
| +207% | +$442K | ﹤0.01% | 814 |
|
|
2020
Q3 | $254K | Buy |
2,390
+880
| +58% | +$122K | ﹤0.01% | 916 |
|
|
2020
Q2 | $228K | Buy |
1,510
+1,000
| +196% | +$98.6K | ﹤0.01% | 891 |
|
|
2020
Q1 | $42K | Buy |
+510
| New | +$71.8K | ﹤0.01% | 1193 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | -$37K | – | 1353 |
|
|
2019
Q3 | $37K | Sell |
200
-1,430
| -88% | -$276K | ﹤0.01% | 1243 |
|
|
2019
Q2 | $372K | Sell |
1,630
-7,980
| -83% | -$1.56M | ﹤0.01% | 914 |
|
|
2019
Q1 | $2.02M | Buy |
+9,610
| New | +$1.8M | 0.03% | 420 |
|
|
2018
Q4 | – | Sell |
-5,390
| Closed | -$1.24M | – | 1603 |
|
|
2018
Q3 | $1.24M | Buy |
5,390
+4,890
| +978% | +$1.08M | 0.01% | 732 |
|
|
2018
Q2 | $111K | Hold |
500
| – | – | ﹤0.01% | 1176 |
|
|
2018
Q1 | $114K | Buy |
+500
| New | +$131K | ﹤0.01% | 1210 |
|
Other funds holding AXDX
AC
GAM
BC
CS
BAM
TWA
